APRIL 2, 2013 BY RAMANAN50 The instances of Multinationals stealing indigenous medicines is well-known. So are the capricious overpricing of life saving Drugs, like Cancer Drugs. “ The Intellectual Property Appellate Board rejected the German drug maker’s appeal of the 2012 ruling on Monday. It also ruled… Continue Reading →
Posted by Ujwala Uppaluri at Oct 31, 2012 http://cis-india.org/ Filed under: Access to Knowledge, Copyright, Intellectual Property Rights, Intermediary Liability, Featured The Delhi High Court’s judgment in Super Cassettes v. MySpace last July is worrying for a number of reasons. The court failed to appreciate the working of… Continue Reading →
Hope for hep-C patients: Context and Background Today, the Bench of Intellectual Property Appellate Board, comprising Justice Prabha Sridevan (Chairperson) and Mr DPS Parmar (Technical Member), set aside the first ever product patent on a medicine granted in India to… Continue Reading →
Some Frequently Asked Questions to the Amendment to the Copyright Act of India, 1957 and its Impact on Print Impaired Persons 1. Who benefits? All print impaired persons be they totally blind, low vision, learning disabled or orthopedically challenged in certain… Continue Reading →
Vandana Shiva Patenting seeds has led to a farming and food crisis – and huge profits for US biotechnology corporations. The seed is the first link in the food chain – and seed sovereignty is the foundation of food sovereignty…. Continue Reading →
India is known as the pharmacy of the world but 65% of Indians have no access to essential medicines. Watch this video to see how the State of Rajasthan in India is tackling the problem by promoting generic medicines and… Continue Reading →
The blockage last week of SOPA, the Stop Online Piracy Act of 2012, is a tentative victory not only for net neutrality and changing definitions of intellectual property, but also an impressive display of new online organizing. SOPA is… Continue Reading →
© 2024 Kractivism — Powered by WordPress
Theme by Anders Noren — Up ↑